Midgard Science

Labs / Assays & in vitro testing

4TEEN4 Pharmaceuticals GmbH

Hennigsdorf, Germany · 4teen4.de

On your own

Free. Their own form.

Contact 4TEEN4 Pharmaceuticals GmbH directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

4TEEN4 Pharmaceuticals GmbH develops a biomarker-driven therapy for shock centered on circulating DPP3 (cDPP3) and its antibody invobenitug (procizumab). The company is headquartered in Hennigsdorf, Germany, and focuses on critically ill patients, especially those with cardiogenic shock.

They take quote requests by email.

What they offer

  • Therapy development for shock

    Advances a first-in-class therapy designed to neutralize circulating DPP3 and address the underlying drivers of shock.

  • Biomarker-driven patient selection

    Uses cDPP3 levels to identify high-risk patients and support patient stratification for shock treatment development.

  • Diagnostic development for cDPP3

    Develops a diagnostic approach based on measuring circulating DPP3 as a prognostic marker in shock.

What they work on

Modalities
Antibody, Peptide
Therapeutic areas
shock, cardiogenic shock, critical care, sepsis, trauma, burns, major surgery
Sites
Hennigsdorf, Germany
Serves
U.S., Europe
Address
Neuendorfstrasse 16B 16761 Hennigsdorf

Similar labs. 3C Therapeutics, Abeomics, ACM Global Laboratories, Alphalyse

Found in a contract services directory. Listing built from 4teen4.de. Work here? Claim this listing.

4TEEN4 Pharmaceuticals GmbH · Midgard Science